Welcome to The Visible Embryo

Home- - -History-- -Bibliography- -Pregnancy Timeline- --Prescription Drugs in Pregnancy- -- Pregnancy Calculator- --Female Reproductive System- News Alerts -Contact

Welcome to The Visible Embryo, a comprehensive educational resource on human development from conception to birth.

The Visible Embryo provides visual references for changes in fetal development throughout pregnancy and can be navigated via fetal development or maternal changes.

The National Institutes of Child Health and Human Development awarded Phase I and Phase II Small Business Innovative Research Grants to develop The Visible Embryo. Initally designed to evaluate the internet as a teaching tool for first year medical students, The Visible Embryo is linked to over 600 educational institutions and is viewed by more than ' million visitors each month.


WHO International Clinical Trials Registry Platform
The World Health Organization (WHO) has created a new Web site to help researchers, doctors and patients obtain reliable information on high-quality clinical trials. Now you can go to one website and search all registers to identify clinical trial research underway around the world!



Home

History

Bibliography

Pregnancy Timeline

Prescription Drug Effects on Pregnancy

Pregnancy Calculator

Female Reproductive System

Contact The Visible Embryo

News Alerts Archive

Disclaimer: The Visible Embryo web site is provided for your general information only. The information contained on this site should not be treated as a substitute for medical, legal or other professional advice. Neither is The Visible Embryo responsible or liable for the contents of any websites of third parties which are listed on this site.
Content protected under a Creative Commons License.

No dirivative works may be made or used for commercial purposes.

Return To Top Of Page
Pregnancy Timeline by SemestersFetal liver is producing blood cellsHead may position into pelvisBrain convolutions beginFull TermWhite fat begins to be madeWhite fat begins to be madeHead may position into pelvisImmune system beginningImmune system beginningPeriod of rapid brain growthBrain convolutions beginLungs begin to produce surfactantSensory brain waves begin to activateSensory brain waves begin to activateInner Ear Bones HardenBone marrow starts making blood cellsBone marrow starts making blood cellsBrown fat surrounds lymphatic systemFetal sexual organs visibleFinger and toe prints appearFinger and toe prints appearHeartbeat can be detectedHeartbeat can be detectedBasic Brain Structure in PlaceThe Appearance of SomitesFirst Detectable Brain WavesA Four Chambered HeartBeginning Cerebral HemispheresFemale Reproductive SystemEnd of Embryonic PeriodEnd of Embryonic PeriodFirst Thin Layer of Skin AppearsThird TrimesterSecond TrimesterFirst TrimesterFertilizationDevelopmental Timeline
Click weeks 0 - 40 and follow fetal growth
Google Search artcles published since 2007
 
May 20, 2011--------News Archive

New Complexity In Genetic Diversity Of RNA
It turns out
RNA proteins do not precisely match the genes that encode them.

Validating Preschool Programs For Autism
Scientists from the Universities of Miami, North Carolina and Colorado, developed measures to evaluate teaching programs for autistic preschool children.


May 19, 2011--------News Archive

New Technique To 'Lift The Hood’ On Autism
A new study provides compelling evidence that exome-sequencing is an effective way to discover which of the 20,000 and more genes in the human genome are responsible for autism spectrum disorders.

Maternal Smoking Causes Changes In Fetal DNA
Children whose mothers or grandmothers smoked during pregnancy are at increased risk of asthma in childhood. A new study indicates changes in DNA methylation occuring before birth may be the root cause.


May 18, 2011--------News Archive

New Antiepileptic Drugs Don't Increase Birth Defects
Use of newer-generation antiepileptic drugs prescribed for bipolar mood disorders and migraine headaches, during the first trimester of pregnancy, are not associated with an increased risk of major birth defects in the first year of life in Denmark.

Neglect And Deprevation Age a Child's Chromosomes
Study of institutionalized Romanian children finds prematurely shortened telomeres, a mark of cell aging.


May 17, 2011--------News Archive

Older Fathers Linked to Autism In Children
Researchers sequenced protein-coding sections of affected childrens' genomes and their findings support population studies showing that autism is more common among children of older parents, especially older fathers.

Gene Variation Linked to Infertility in Women
A variation in a gene involved in regulating cholesterol also appears to affect progesterone in women, making it a likely culprit in cases of infertility.


May 16, 2011--------News Archive

Genetic Clue to Common Birth Defects Found
Scientists at King’s College London have for the first time uncovered a gene responsible for Adams-Oliver Syndrome, giving valuable insight into the possible genetic causes of common birth defects found in the wider population.

'Master switch' For Obesity and Diabetes Discovered
A gene linked to type 2 diabetes and cholesterol levels is in fact a 'master regulator' gene, which controls other genes found within fat in the body.

Tiny Change in One Gene May Explain Human Brain
The deep fissures and convolutions that increase the surface area and allow for rational and abstract thoughts of the human brain may be due to the LAMC3 gene.

Gene Change Can Get You Cancer Or Normal Growth
The deep fissures and convolutions that increase the surface area and allow for rational and abstract thoughts of the human brain may be due to one gene.


WHO Child Growth Charts


Other genes found to be controlled by KLF14 are in fact linked to a range of metabolic traits, including body-mass index (obesity), cholesterol, insulin and glucose levels.

A team of researchers, led by King's College London and the University of Oxford, have found that a gene linked to type 2 diabetes and cholesterol levels is in fact a 'master regulator' gene, which controls the behaviour of other genes found within fat in the body.

As fat plays a key role in susceptibility to metabolic diseases such as obesity, heart disease and diabetes, this study highlights this regulatory gene as a possible target for future treatments to fight these diseases.

Published today in Nature Genetics, the study was one part of a large multi-national collaboration funded by the Wellcome Trust, known as the MuTHER study. It involves researchers from King's College London, University of Oxford, The Wellcome Trust Sanger Institute, and the University of Geneva. DeCODE Genetics also contributed to the results reported in this paper.

It was already known that the KLF14 gene is linked to type 2 diabetes and cholesterol levels but, until now, how it did this and the role it played in controlling other genes located further away on the genome was unknown.

The researchers examined over 20,000 genes in subcutaneous fat biopsies from 800 UK female twin volunteers. They found an association between the KLF14 gene and the expression levels of multiple distant genes found in fat tissue, which means KLF14 acts as a master switch to control these genes. This was then confirmed in another independent sample of 600 subcutaneous fat biopsies from Icelandic subjects.

Other genes found to be controlled by KLF14 are in fact linked to a range of metabolic traits, including body-mass index (obesity), cholesterol, insulin and glucose levels, highlighting the interconnections of these traits.

The KLF14 gene is special in that its activity is inherited from the mother. Each person inherits a set of all genes from both parents. But in this case, the copy of KLF14 from the father is switched off, meaning that the copy from the mother is the active gene – a process called imprinting. Moreover, the ability of KLF14 to control other genes was entirely dependent on the copy of KLF14 inherited from the mother – the copy inherited from the father had no effect.

Professor Tim Spector from the Department of Twin Research at King's, who led the MuTHER project, said: 'This is the first major study that shows how small changes in one master regulator gene can cause a cascade of other metabolic effects in other genes. This has great therapeutic potential particularly as by studying large detailed populations such as the twins we hope to find more of these regulators.'

Professor Mark McCarthy from the University of Oxford, who co-led the study, said: 'KLF14 seems to act as a master switch controlling processes that connect changes in the behaviour of subcutaneous fat to disturbances in muscle and liver that contribute to diabetes and other conditions. We are working hard right now to understand these processes and how we can use this information to improve treatment of these conditions.'

The MuTHER study stands for the Multiple Tissue Human Expression Resource study and is a five year program grant funded by the Wellcome Trust. The consortium involves over 30 scientists from the UK and Switzerland. The coordinator is Professor Spector at King's and the other lead PIs are Professor McCarthy at Oxford, Dr Deloukas at the Wellcome Trust Sanger Institute in Hinxton and Professor Demitzakis at University of Geneva. 850 female twins have had skin, fat and blood cells collected as well as hundreds of clinical traits assessed. The overall aim of the study is to use the unique detailed genetic, genomic and phenotypic data generated from the TwinsUK study to understand the mechanisms of how genes influence common age-related and metabolic diseases. (www.muther.ac.uk)